Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention

doi:10.12998/wjcc.v9.i36.11248

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 36

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2608)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

229

WORD

HTML

1589

Tables (1-3)

146

Sum=2048

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

170

Download

390

Sum=560

Dec 26, 2021 (publication date) through Jun 9, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Dec 26, 2021; 9(36): 11248-11254
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11248

Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention

Yan Yu, Bao-Ping Yang

Yan Yu, Bao-Ping Yang, Department of Cardiovascular Medicine, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, Gansu Province, China

Author contributions: Yu Y and Yang BP contributed to the writing and revising of the manuscript.

Supported by 2020 Gansu Planning Projects on Science and Technology, No. 20JR10RA352.

Institutional review board statement: The study was reviewed and approved by the Gansu Provincial Hospital of Traditional Chinese Medicine Institutional Review Board.

Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.

Conflict-of-interest statement: None.

Data sharing statement: No additional data are available.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Bao-Ping Yang, BSc, Associate Chief Physician, Department of Cardiovascular Medicine, Gansu Provincial Hospital of Traditional Chinese Medicine, No. 418 Guazhou Road, Qilihe District, Lanzhou 730050, Gansu Province, China. ybp1788@163.com

Received: August 10, 2021
Peer-review started: August 10, 2021
First decision: September 2, 2021
Revised: October 7, 2021
Accepted: November 3, 2021
Article in press: November 3, 2021
Published online: December 26, 2021

Core Tip

Core Tip: The present study explored the effectiveness of coronary injection with nitroprusside, a commonly used vasodilator, as a pharmacological intervention strategy administered before balloon inflation for the prevention of no reflow or slow flow during percutaneous coronary intervention. The results showed that preventive use of sodium nitroprusside proved beneficial. It resulted in improved coronary blood flow and outcome of percutaneous coronary intervention.